United States · 
Who invested in Crux Therapeutics?
Crux Therapeutics's investors include Goldman Sachs, Citibank and Two Sigma.
United States · Series B startup
Who invested in Crux Therapeutics
One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$20Mraised across 1 round since 2018, from 1 source
- Latest round
- Series B, $20MOct 2018
- Investors
- 3
The rounds
- Oct 2018
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Crux Therapeutics
How much has Crux Therapeutics raised?
Crux Therapeutics has raised $20M across 1 round since 2018.
When did Crux Therapeutics last raise?
Crux Therapeutics's most recent round was a Series B of $20M in Oct 2018.
What was Crux Therapeutics's biggest round?
Its most recent round, $20M in Oct 2018, is also its largest on record.
Who backed Crux Therapeutics first?
Crux Therapeutics's first round on record, in Oct 2018, was backed by Goldman Sachs, Citibank and Two Sigma.
What stage is Crux Therapeutics at?
Crux Therapeutics's latest named round is a Series B, in Oct 2018.
Where is Crux Therapeutics based?
Crux Therapeutics is based in the United States.
Companies like Crux Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.